Loading data for SLXN — first visit, this takes a few seconds.
Silexion Therapeutics Corp (SLXN)
NasdaqCM: SLXN
· Real-Time Price · USD
0.37
+0.00 (0.00%)
At close: Sep 04, 2026, 8:00 PM
0.36
+1.99%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Silexion Therapeutics Corp (SLXN) Stock Price, Analysis & Data
No data available
| Bid | 0.27 |
| Market Cap | 1.96M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -14M |
| -0.36 | |
| -19.91 | |
| n/a | |
| -0.55 | |
| P/B (ttm) | 43.98 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 0.48 |
| Volume | 175,262 |
| Avg. Volume (20D) | 281,361 |
| Open | 0.36 |
| Previous Close | 0.37 |
| Day's Range | 0.36 - 0.39 |
| 52-Week Range | 0.35 - 77.70 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SLXN
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER,...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 7, 2021
Employees 13
Stock Exchange NasdaqCM
Ticker Symbol SLXN
Website https://silexion.com
Financial Performance
In 2025, Silexion Therapeutics Corp's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -11.91M, a decrease of -27.56%.
Financial StatementsEarnings Surprise
Silexion Therapeutics Corp has released their quarterly earnings on Aug 14, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -5.17 misses estimates by -3.05, with 99.81% YoY growth.